Karen Lackey, CEO of X-Chem, has been at the forefront of integrated drug discovery across her over 30-year career. Hear her story and insights on the future of drug discovery in her appearance on the Molecule to Market podcast.

Listen now to explore:

• How diversity of thought enables problem-solving
• Karen’s journey from big pharma to leading biotech innovation
• How Karen’s experience empowers her to redefine drug discovery at X-Chem
• A holistic view of AI/ML in drug discovery, enabling more accessible and capital-efficient use
• Karen’s views on biotech failures and how to rethink launches